Timothy Rolph, the Chief Scientific Officer of $AKRO, sold 5,538 shares of the company on 08-05-2025 for an estimated $271,721. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares of this class of stock. Following this trade, they now own 174,086 shares of this class of $AKRO stock.
$AKRO Insider Trading Activity
$AKRO insiders have traded $AKRO stock on the open market 79 times in the past 6 months. Of those trades, 3 have been purchases and 76 have been sales.
Here’s a breakdown of recent trading of $AKRO stock by insiders over the last 6 months:
- ANDREW CHENG (President and CEO) has made 0 purchases and 17 sales selling 196,195 shares for an estimated $9,157,175.
- G. WALMSLEY GRAHAM has made 3 purchases buying 200,000 shares for an estimated $8,787,921 and 0 sales.
- TIMOTHY ROLPH (Chief Scientific Officer) has made 0 purchases and 21 sales selling 104,003 shares for an estimated $5,092,141.
- CATRIONA YALE (Chief Development Officer) has made 0 purchases and 17 sales selling 64,123 shares for an estimated $3,023,439.
- JONATHAN YOUNG (Chief Operating Officer) has made 0 purchases and 5 sales selling 54,553 shares for an estimated $2,484,742.
- PATRICK LAMY (Senior VP, Commercial Strategy) has made 0 purchases and 12 sales selling 22,794 shares for an estimated $1,100,720.
- WILLIAM RICHARD WHITE (Chief Financial Officer) has made 0 purchases and 3 sales selling 5,114 shares for an estimated $271,349.
- SCOTT A. GANGLOFF (Chief Technology Officer) sold 848 shares for an estimated $46,504
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AKRO Hedge Fund Activity
We have seen 158 institutional investors add shares of $AKRO stock to their portfolio, and 84 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 1,784,562 shares (+479.9%) to their portfolio in Q1 2025, for an estimated $72,239,069
- DEEP TRACK CAPITAL, LP added 1,720,270 shares (+115.5%) to their portfolio in Q1 2025, for an estimated $69,636,529
- WELLINGTON MANAGEMENT GROUP LLP removed 1,440,721 shares (-19.5%) from their portfolio in Q1 2025, for an estimated $58,320,386
- MARSHALL WACE, LLP added 1,332,768 shares (+484.5%) to their portfolio in Q1 2025, for an estimated $53,950,448
- BELLEVUE GROUP AG added 1,250,666 shares (+inf%) to their portfolio in Q1 2025, for an estimated $50,626,959
- JANUS HENDERSON GROUP PLC added 1,034,409 shares (+17.1%) to their portfolio in Q1 2025, for an estimated $41,872,876
- FMR LLC added 970,403 shares (+2505.9%) to their portfolio in Q1 2025, for an estimated $39,281,913
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AKRO Analyst Ratings
Wall Street analysts have issued reports on $AKRO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 08/04/2025
- B of A Securities issued a "Buy" rating on 05/27/2025
- Citigroup issued a "Buy" rating on 05/13/2025
- HC Wainwright & Co. issued a "Buy" rating on 03/03/2025
To track analyst ratings and price targets for $AKRO, check out Quiver Quantitative's $AKRO forecast page.
$AKRO Price Targets
Multiple analysts have issued price targets for $AKRO recently. We have seen 4 analysts offer price targets for $AKRO in the last 6 months, with a median target of $75.5.
Here are some recent targets:
- Ritu Baral from TD Cowen set a target price of $76.0 on 08/04/2025
- Alexandria Hammond from B of A Securities set a target price of $64.0 on 05/27/2025
- Jonathan Woo from Citigroup set a target price of $78.0 on 05/13/2025
- Ed Arce from HC Wainwright & Co. set a target price of $75.0 on 03/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
